APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fidaxomicin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Fidaxomicin Industry Growth and Trends Forecast to 2032

27 December 202596 pages

Choose your research edition.

Industry ResearchFidaxomicin Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Fidaxomicin Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Fidaxomicin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fidaxomicin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Fidaxomicin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Fidaxomicin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Fidaxomicin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Fidaxomicin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fidaxomicin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fidaxomicin include Merck, Livzon Group, Tecoland, Rochem, Optimer Pharmaceuticals, Olon, BrightGene Bio-Medical Technology and Astellas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Fidaxomicin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Fidaxomicin market size, estimates, and forecasts are presented in terms of sales volume (W Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fidaxomicin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fidaxomicin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Fidaxomicin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Fidaxomicin Market by Company

Merck

Livzon Group

Tecoland

Rochem

Optimer Pharmaceuticals

Olon

BrightGene Bio-Medical Technology

Astellas

Fidaxomicin Segment by Type

Purity:90%

Purity:95%

Others

Fidaxomicin Segment by Application

Hospital

Retail Pharmacies

Fidaxomicin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fidaxomicin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fidaxomicin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fidaxomicin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fidaxomicin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Fidaxomicin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity:90% Table 2. Major Company of Purity:95% Table 3. Major Company of Others Table 4. Global Fidaxomicin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Fidaxomicin Sales by Type (2021-2026) & (W Pcs) Table 6. Global Fidaxomicin Sales Market Share in Volume by Type (2021-2026) Table 7. Global Fidaxomicin Sales by Type (2021-2026) & (US$ Million) Table 8. Global Fidaxomicin Sales Market Share in Value by Type (2021-2026) Table 9. Global Fidaxomicin Price by Type (2021-2026) & (US$/Pcs) Table 10. Global Fidaxomicin Sales by Type (2027-2032) & (W Pcs) Table 11. Global Fidaxomicin Sales Market Share in Volume by Type (2027-2032) Table 12. Global Fidaxomicin Sales by Type (2027-2032) & (US$ Million) Table 13. Global Fidaxomicin Sales Market Share in Value by Type (2027-2032) Table 14. Global Fidaxomicin Price by Type (2027-2032) & (US$/Pcs) Table 15. North America Fidaxomicin Sales by Type (2021-2026) & (W Pcs) Table 16. North America Fidaxomicin Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Fidaxomicin Sales by Type (2021-2026) & (W Pcs) Table 18. Europe Fidaxomicin Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Fidaxomicin Sales by Type (2021-2026) & (W Pcs) Table 20. Asia-Pacific Fidaxomicin Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Fidaxomicin Sales by Type (2021-2026) & (W Pcs) Table 22. Latin America Fidaxomicin Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Fidaxomicin Sales by Type (2021-2026) & (W Pcs) Table 24. Middle East and Africa Fidaxomicin Sales by Type (2021-2026) & (US$ Million) Table 25. Fidaxomicin Industry Trends Table 26. Fidaxomicin Industry Drivers Table 27. Fidaxomicin Industry Opportunities and Challenges Table 28. Fidaxomicin Industry Restraints Table 29. Global Fidaxomicin Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Fidaxomicin Revenue Market Share by Company (2021-2026) Table 31. Global Fidaxomicin Sales by Company (2021-2026) & (W Pcs) Table 32. Global Fidaxomicin Sales Share by Company (2021-2026) Table 33. Global Fidaxomicin Market Price by Company (2021-2026) & (US$/Pcs) Table 34. Global Fidaxomicin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Fidaxomicin Major Company Production Sites and Headquarters Table 36. Global Fidaxomicin Company, Product Type & Application Table 37. Global Fidaxomicin Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Fidaxomicin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Fidaxomicin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Fidaxomicin Sales by Region (2021-2026) & (W Pcs) Table 42. Global Fidaxomicin Sales Market Share in Volume by Region (2021-2026) Table 43. Global Fidaxomicin Sales by Region (2021-2026) & (US$ Million) Table 44. Global Fidaxomicin Sales Market Share in Value by Region (2021-2026) Table 45. Global Fidaxomicin Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 46. Global Fidaxomicin Sales by Region (2027-2032) & (W Pcs) Table 47. Global Fidaxomicin Sales Market Share in Volume by Region (2027-2032) Table 48. Global Fidaxomicin Sales by Region (2027-2032) & (US$ Million) Table 49. Global Fidaxomicin Sales Market Share in Value by Region (2027-2032) Table 50. Global Fidaxomicin Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 51. Global Fidaxomicin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Fidaxomicin Sales by Application (2021-2026) & (W Pcs) Table 53. Global Fidaxomicin Sales Market Share in Volume by Application (2021-2026) Table 54. Global Fidaxomicin Sales by Application (2021-2026) & (US$ Million) Table 55. Global Fidaxomicin Sales Market Share in Value by Application (2021-2026) Table 56. Global Fidaxomicin Price by Application (2021-2026) & (US$/Pcs) Table 57. Global Fidaxomicin Sales by Application (2027-2032) & (W Pcs) Table 58. Global Fidaxomicin Sales Market Share in Volume by Application (2027-2032) Table 59. Global Fidaxomicin Sales by Application (2027-2032) & (US$ Million) Table 60. Global Fidaxomicin Sales Market Share in Value by Application (2027-2032) Table 61. Global Fidaxomicin Price by Application (2027-2032) & (US$/Pcs) Table 62. North America Fidaxomicin Sales by Application (2021-2026) & (W Pcs) Table 63. North America Fidaxomicin Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Fidaxomicin Sales by Application (2021-2026) & (W Pcs) Table 65. Europe Fidaxomicin Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Fidaxomicin Sales by Application (2021-2026) & (W Pcs) Table 67. Asia-Pacific Fidaxomicin Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Fidaxomicin Sales by Application (2021-2026) & (W Pcs) Table 69. Latin America Fidaxomicin Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Fidaxomicin Sales by Application (2021-2026) & (W Pcs) Table 71. Middle East and Africa Fidaxomicin Sales by Application (2021-2026) & (US$ Million) Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Fidaxomicin Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 75. Merck Fidaxomicin Product Portfolio Table 76. Merck Recent Development Table 77. Livzon Group Company Information Table 78. Livzon Group Business Overview Table 79. Livzon Group Fidaxomicin Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 80. Livzon Group Fidaxomicin Product Portfolio Table 81. Livzon Group Recent Development Table 82. Tecoland Company Information Table 83. Tecoland Business Overview Table 84. Tecoland Fidaxomicin Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 85. Tecoland Fidaxomicin Product Portfolio Table 86. Tecoland Recent Development Table 87. Rochem Company Information Table 88. Rochem Business Overview Table 89. Rochem Fidaxomicin Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 90. Rochem Fidaxomicin Product Portfolio Table 91. Rochem Recent Development Table 92. Optimer Pharmaceuticals Company Information Table 93. Optimer Pharmaceuticals Business Overview Table 94. Optimer Pharmaceuticals Fidaxomicin Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 95. Optimer Pharmaceuticals Fidaxomicin Product Portfolio Table 96. Optimer Pharmaceuticals Recent Development Table 97. Olon Company Information Table 98. Olon Business Overview Table 99. Olon Fidaxomicin Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 100. Olon Fidaxomicin Product Portfolio Table 101. Olon Recent Development Table 102. BrightGene Bio-Medical Technology Company Information Table 103. BrightGene Bio-Medical Technology Business Overview Table 104. BrightGene Bio-Medical Technology Fidaxomicin Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 105. BrightGene Bio-Medical Technology Fidaxomicin Product Portfolio Table 106. BrightGene Bio-Medical Technology Recent Development Table 107. Astellas Company Information Table 108. Astellas Business Overview Table 109. Astellas Fidaxomicin Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 110. Astellas Fidaxomicin Product Portfolio Table 111. Astellas Recent Development Table 112. North America Fidaxomicin Market Size Growth Rate (CAGR) by Country (W Pcs): 2021 VS 2025 VS 2032 Table 113. North America Fidaxomicin Sales by Country (2021-2026) & (W Pcs) Table 114. North America Fidaxomicin Sales Market Share by Country (2021-2026) Table 115. North America Fidaxomicin Sales Forecast by Country (2027-2032) & (W Pcs) Table 116. North America Fidaxomicin Sales Market Share Forecast by Country (2027-2032) Table 117. North America Fidaxomicin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Fidaxomicin Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Fidaxomicin Market Share by Country (2021-2026) Table 120. North America Fidaxomicin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Fidaxomicin Market Share Forecast by Country (2027-2032) Table 122. Europe Fidaxomicin Market Size Growth Rate (CAGR) by Country (W Pcs): 2021 VS 2025 VS 2032 Table 123. Europe Fidaxomicin Sales by Country (2021-2026) & (W Pcs) Table 124. Europe Fidaxomicin Sales Market Share by Country (2021-2026) Table 125. Europe Fidaxomicin Sales Forecast by Country (2027-2032) & (W Pcs) Table 126. Europe Fidaxomicin Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Fidaxomicin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Fidaxomicin Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Fidaxomicin Market Share by Country (2021-2026) Table 130. Europe Fidaxomicin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Fidaxomicin Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Fidaxomicin Market Size Growth Rate (CAGR) by Country (W Pcs): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Fidaxomicin Sales by Country (2021-2026) & (W Pcs) Table 134. Asia-Pacific Fidaxomicin Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Fidaxomicin Sales Forecast by Country (2027-2032) & (W Pcs) Table 136. Asia-Pacific Fidaxomicin Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Fidaxomicin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Fidaxomicin Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Fidaxomicin Market Share by Country (2021-2026) Table 140. Asia-Pacific Fidaxomicin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Fidaxomicin Market Share Forecast by Country (2027-2032) Table 142. Latin America Fidaxomicin Market Size Growth Rate (CAGR) by Country (W Pcs): 2021 VS 2025 VS 2032 Table 143. Latin America Fidaxomicin Sales by Country (2021-2026) & (W Pcs) Table 144. Latin America Fidaxomicin Sales Market Share by Country (2021-2026) Table 145. Latin America Fidaxomicin Sales Forecast by Country (2027-2032) & (W Pcs) Table 146. Latin America Fidaxomicin Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Fidaxomicin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Fidaxomicin Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Fidaxomicin Market Share by Country (2021-2026) Table 150. Latin America Fidaxomicin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Fidaxomicin Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Fidaxomicin Market Size Growth Rate (CAGR) by Country (W Pcs): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Fidaxomicin Sales by Country (2021-2026) & (W Pcs) Table 154. Middle East and Africa Fidaxomicin Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Fidaxomicin Sales Forecast by Country (2027-2032) & (W Pcs) Table 156. Middle East and Africa Fidaxomicin Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Fidaxomicin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Fidaxomicin Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Fidaxomicin Market Share by Country (2021-2026) Table 160. Middle East and Africa Fidaxomicin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Fidaxomicin Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Fidaxomicin Distributors List Table 165. Fidaxomicin Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Fidaxomicin Image Figure 2. Global Fidaxomicin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fidaxomicin Market Size (2021-2032) & (US$ Million) Figure 4. Global Fidaxomicin Sales (2021-2032) & (W Pcs) Figure 5. Purity:90% Image Figure 6. Global Purity:90% Sales YoY Growth (2021-2032) & (W Pcs) Figure 7. Purity:95% Image Figure 8. Global Purity:95% Sales YoY Growth (2021-2032) & (W Pcs) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (W Pcs) Figure 11. Global Fidaxomicin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Fidaxomicin Market Share by Type 2025 VS 2032 Figure 13. North America Fidaxomicin Sales Market Share in Volume by Type in 2025 Figure 14. North America Fidaxomicin Sales Market Share in Value by Type in 2025 Figure 15. Europe Fidaxomicin Sales Market Share in Volume by Type in 2025 Figure 16. Europe Fidaxomicin Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Fidaxomicin Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Fidaxomicin Sales Market Share in Value by Type in 2025 Figure 19. Latin America Fidaxomicin Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Fidaxomicin Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Fidaxomicin Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Fidaxomicin Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Fidaxomicin Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (W Pcs) Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (W Pcs) Figure 29. Global Fidaxomicin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Fidaxomicin Market Share by Application 2025 VS 2032 Figure 31. North America Fidaxomicin Sales Market Share in Volume by Application in 2025 Figure 32. North America Fidaxomicin Sales Market Share in Value by Application in 2025 Figure 33. Europe Fidaxomicin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Fidaxomicin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Fidaxomicin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Fidaxomicin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Fidaxomicin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Fidaxomicin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Fidaxomicin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Fidaxomicin Sales Market Share in Value by Application in 2025 Figure 41. North America Fidaxomicin Sales by Country: 2021 VS 2025 VS 2032 (W Pcs) Figure 42. North America Fidaxomicin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Fidaxomicin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Fidaxomicin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Fidaxomicin Sales by Country: 2021 VS 2025 VS 2032 (W Pcs) Figure 46. Europe Fidaxomicin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Fidaxomicin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Fidaxomicin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Fidaxomicin Sales by Country: 2021 VS 2025 VS 2032 (W Pcs) Figure 50. Asia-Pacific Fidaxomicin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Fidaxomicin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Fidaxomicin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Fidaxomicin Sales by Country: 2021 VS 2025 VS 2032 (W Pcs) Figure 54. Latin America Fidaxomicin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Fidaxomicin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Fidaxomicin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Fidaxomicin Sales by Country: 2021 VS 2025 VS 2032 (W Pcs) Figure 58. Middle East and Africa Fidaxomicin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Fidaxomicin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Fidaxomicin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Fidaxomicin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Fidaxomicin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Purity:90%
  • Purity:95%
  • Others
Applications
  • Hospital
  • Retail Pharmacies
Companies covered
  • Merck
  • Livzon Group
  • Tecoland
  • Rochem
  • Optimer Pharmaceuticals
  • Olon
  • BrightGene Bio-Medical Technology
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fidaxomicin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Fidaxomicin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Fidaxomicin Market by Type
  6. 1.3.1 Purity:90%
  7. 1.3.2 Purity:95%
  8. 1.3.3 Others
  9. 1.4 Global Fidaxomicin Market Size by Type
  10. 1.4.1 Global Fidaxomicin Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Fidaxomicin Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Fidaxomicin Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Fidaxomicin Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Fidaxomicin Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Fidaxomicin Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Fidaxomicin Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Fidaxomicin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Fidaxomicin Industry Trends
  2. 2.2 Fidaxomicin Industry Drivers
  3. 2.3 Fidaxomicin Industry Opportunities and Challenges
  4. 2.4 Fidaxomicin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Fidaxomicin Revenue (2021-2026)
  2. 3.2 Global Top Players by Fidaxomicin Sales (2021-2026)
  3. 3.3 Global Top Players by Fidaxomicin Price (2021-2026)
  4. 3.4 Global Fidaxomicin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fidaxomicin Major Company Production Sites & Headquarters
  6. 3.6 Global Fidaxomicin Company, Product Type & Application
  7. 3.7 Global Fidaxomicin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fidaxomicin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fidaxomicin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fidaxomicin Tier 1, Tier 2, and Tier 3
4 Fidaxomicin Regional Status and Outlook
  1. 4.1 Global Fidaxomicin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Fidaxomicin Historic Market Size by Region
  3. 4.2.1 Global Fidaxomicin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Fidaxomicin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Fidaxomicin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Fidaxomicin Forecasted Market Size by Region
  7. 4.3.1 Global Fidaxomicin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Fidaxomicin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Fidaxomicin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Fidaxomicin by Application
  1. 5.1 Fidaxomicin Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacies
  4. 5.2 Global Fidaxomicin Market Size by Application
  5. 5.2.1 Global Fidaxomicin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Fidaxomicin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Fidaxomicin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Fidaxomicin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Fidaxomicin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Fidaxomicin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Fidaxomicin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Fidaxomicin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Fidaxomicin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Fidaxomicin Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Livzon Group
  8. 6.2.1 Livzon Group Company Information
  9. 6.2.2 Livzon Group Business Overview
  10. 6.2.3 Livzon Group Fidaxomicin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Livzon Group Fidaxomicin Product Portfolio
  12. 6.2.5 Livzon Group Recent Developments
  13. 6.3 Tecoland
  14. 6.3.1 Tecoland Company Information
  15. 6.3.2 Tecoland Business Overview
  16. 6.3.3 Tecoland Fidaxomicin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tecoland Fidaxomicin Product Portfolio
  18. 6.3.5 Tecoland Recent Developments
  19. 6.4 Rochem
  20. 6.4.1 Rochem Company Information
  21. 6.4.2 Rochem Business Overview
  22. 6.4.3 Rochem Fidaxomicin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Rochem Fidaxomicin Product Portfolio
  24. 6.4.5 Rochem Recent Developments
  25. 6.5 Optimer Pharmaceuticals
  26. 6.5.1 Optimer Pharmaceuticals Company Information
  27. 6.5.2 Optimer Pharmaceuticals Business Overview
  28. 6.5.3 Optimer Pharmaceuticals Fidaxomicin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Optimer Pharmaceuticals Fidaxomicin Product Portfolio
  30. 6.5.5 Optimer Pharmaceuticals Recent Developments
  31. 6.6 Olon
  32. 6.6.1 Olon Company Information
  33. 6.6.2 Olon Business Overview
  34. 6.6.3 Olon Fidaxomicin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Olon Fidaxomicin Product Portfolio
  36. 6.6.5 Olon Recent Developments
  37. 6.7 BrightGene Bio-Medical Technology
  38. 6.7.1 BrightGene Bio-Medical Technology Company Information
  39. 6.7.2 BrightGene Bio-Medical Technology Business Overview
  40. 6.7.3 BrightGene Bio-Medical Technology Fidaxomicin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 BrightGene Bio-Medical Technology Fidaxomicin Product Portfolio
  42. 6.7.5 BrightGene Bio-Medical Technology Recent Developments
  43. 6.8 Astellas
  44. 6.8.1 Astellas Company Information
  45. 6.8.2 Astellas Business Overview
  46. 6.8.3 Astellas Fidaxomicin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Astellas Fidaxomicin Product Portfolio
  48. 6.8.5 Astellas Recent Developments
7 North America by Country
  1. 7.1 North America Fidaxomicin Sales by Country
  2. 7.1.1 North America Fidaxomicin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Fidaxomicin Sales by Country (2021-2026)
  4. 7.1.3 North America Fidaxomicin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Fidaxomicin Market Size by Country
  6. 7.2.1 North America Fidaxomicin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Fidaxomicin Market Size by Country (2021-2026)
  8. 7.2.3 North America Fidaxomicin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Fidaxomicin Sales by Country
  2. 8.1.1 Europe Fidaxomicin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Fidaxomicin Sales by Country (2021-2026)
  4. 8.1.3 Europe Fidaxomicin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Fidaxomicin Market Size by Country
  6. 8.2.1 Europe Fidaxomicin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Fidaxomicin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Fidaxomicin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Fidaxomicin Sales by Country
  2. 9.1.1 Asia-Pacific Fidaxomicin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Fidaxomicin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Fidaxomicin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Fidaxomicin Market Size by Country
  6. 9.2.1 Asia-Pacific Fidaxomicin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Fidaxomicin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Fidaxomicin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Fidaxomicin Sales by Country
  2. 10.1.1 South America Fidaxomicin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Fidaxomicin Sales by Country (2021-2026)
  4. 10.1.3 South America Fidaxomicin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Fidaxomicin Market Size by Country
  6. 10.2.1 South America Fidaxomicin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Fidaxomicin Market Size by Country (2021-2026)
  8. 10.2.3 South America Fidaxomicin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Fidaxomicin Sales by Country
  2. 11.1.1 Middle East and Africa Fidaxomicin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Fidaxomicin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Fidaxomicin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Fidaxomicin Market Size by Country
  6. 11.2.1 Middle East and Africa Fidaxomicin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Fidaxomicin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Fidaxomicin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Fidaxomicin Value Chain Analysis
  2. 12.1.1 Fidaxomicin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Fidaxomicin Production Mode & Process
  7. 12.2 Fidaxomicin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Fidaxomicin Distributors
  10. 12.2.3 Fidaxomicin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst